Literature DB >> 10556323

Cloning and characterization of human oncostatin M promoter.

Y Ma1, R J Streiff, J Liu, M J Spence, R E Vestal.   

Abstract

Oncostatin M (OSM), an IL-6 subfamily cytokine, inhibits proliferation and causes morphological changes in many tumor cell lines. GM-CSF, phorbol-12-myristate-13-acetate (PMA), and lipopolysaccharide (LPS) induce OSM expression. To investigate the mechanisms governing OSM promoter activity, we have cloned and partially sequenced an 8.5 kb fragment of human genomic DNA immediately 5' of the OSM coding region and mapped the transcription start site. Transient transfection assays with a series of 5' deletion plasmids demonstrated maximal reporter activity in U937 cells with a minimum 304 bp construct. The 5'-proximal region of the human OSM gene contains a C/EBP consensus element around -45 bp and several GC-rich regions around -60, each of which is responsible for basal promoter activity. Electrophoretic mobility shift assay coupled with supershift analysis confirmed the presence of a cis -acting binding site for activated STAT5 complexes following GM-CSF treatment. Furthermore, transient transfection studies demonstrated a loss of GM-CSF responsiveness in reporter constructs containing mutations within this STAT element. Our results establish that C/EBP and an as yet unidentified GC-rich binding transcription factor are responsible for basal OSM promoter activity, while GM-CSF-stimulated OSM expression is driven by activated STAT5 complexes binding to a cis -acting STAT element on the OSM promoter.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10556323      PMCID: PMC148755          DOI: 10.1093/nar/27.23.4649

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  8 in total

1.  Identification of human STAT5-dependent gene regulatory elements based on interspecies homology.

Authors:  Erik A Nelson; Sarah R Walker; Wei Li; X Shirley Liu; David A Frank
Journal:  J Biol Chem       Date:  2006-07-13       Impact factor: 5.157

2.  Early growth response-1 attenuates liver injury and promotes hepatoprotection after carbon tetrachloride exposure in mice.

Authors:  Michele T Pritchard; Jessica I Cohen; Sanjoy Roychowdhury; Brian T Pratt; Laura E Nagy
Journal:  J Hepatol       Date:  2010-06-10       Impact factor: 25.083

3.  Resveratrol Downregulates Granulocyte-Macrophage Colony-Stimulating Factor-Induced Oncostatin M Production through Blocking of PI3K/Akt/NF-κB Signal Cascade in Neutrophil-like Differentiated HL-60 Cells.

Authors:  Na-Ra Han; Hi-Joon Park; Phil-Dong Moon
Journal:  Curr Issues Mol Biol       Date:  2022-01-22       Impact factor: 2.976

4.  JAK1/STAT3 Activation through a Proinflammatory Cytokine Pathway Leads to Resistance to Molecularly Targeted Therapy in Non-Small Cell Lung Cancer.

Authors:  Kazuhiko Shien; Vassiliki A Papadimitrakopoulou; Dennis Ruder; Carmen Behrens; Li Shen; Neda Kalhor; Juhee Song; J Jack Lee; Jing Wang; Ximing Tang; Roy S Herbst; Shinichi Toyooka; Luc Girard; John D Minna; Jonathan M Kurie; Ignacio I Wistuba; Julie G Izzo
Journal:  Mol Cancer Ther       Date:  2017-07-20       Impact factor: 6.261

5.  Prostaglandin E₂ induces oncostatin M expression in human chronic wound macrophages through Axl receptor tyrosine kinase pathway.

Authors:  Kasturi Ganesh; Amitava Das; Ryan Dickerson; Savita Khanna; Narasimham L Parinandi; Gayle M Gordillo; Chandan K Sen; Sashwati Roy
Journal:  J Immunol       Date:  2012-07-27       Impact factor: 5.422

6.  Prostaglandin E2 is a novel inducer of oncostatin-M expression in macrophages and microglia.

Authors:  Pavle Repovic; Etty N Benveniste
Journal:  J Neurosci       Date:  2002-07-01       Impact factor: 6.167

7.  Dexamethasone Attenuates Oncostatin M Production via Suppressing of PI3K/Akt/NF-κB Signaling in Neutrophil-like Differentiated HL-60 Cells.

Authors:  Na-Ra Han; Seong-Gyu Ko; Hi-Joon Park; Phil-Dong Moon
Journal:  Molecules       Date:  2021-12-27       Impact factor: 4.411

Review 8.  Historical overview of the interleukin-6 family cytokine.

Authors:  Sujin Kang; Masashi Narazaki; Hozaifa Metwally; Tadamitsu Kishimoto
Journal:  J Exp Med       Date:  2020-05-04       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.